Related Experiment Videos

Deletion of a consensus oestrogen response element half-site in the glucocorticoid receptor of human multiple myeloma

J D Karkera1, S E Taymans, G Turner

  • 1Medical Oncology Section, Department of Veterans Affairs Medical Center, Washington, D.C. 20422, U.S.A.

Insights

Glucocorticoid receptor (GR) mutations in multiple myeloma cells were identified. A deletion in the 3' untranslated region may impact mRNA stability and gene regulation.

Area of Science:

  • Molecular biology
  • Genetics
  • Cancer research

Background:

  • Multiple myeloma is a cancer of plasma cells.
  • Glucocorticoid resistance is a challenge in multiple myeloma treatment.
  • The glucocorticoid receptor (GR) plays a role in cellular response to glucocorticoids.

Purpose of the Study:

  • To investigate the molecular basis of glucocorticoid resistance in the U266 multiple myeloma cell line.
  • To identify mutations in the glucocorticoid receptor (GR) gene.

Main Methods:

  • Molecular scanning of the glucocorticoid receptor (GR) in U266 cells.
  • Polymerase chain reaction-single-stranded conformational polymorphism (PCR-SSCP) analysis.
  • DNA sequencing to identify mutations.

Main Results:

  • An aberrant migration pattern was observed in a PCR-amplified fragment from the 3' untranslated region of the GR gene.
  • A mutant allele exhibited an 8 base pair deletion within a half-site of an oestrogen response element (ERE).
  • The mutant allele also showed a difference in a polyadenine tract compared to the normal allele.

Conclusions:

  • The identified mutations in the GR 3' untranslated region may contribute to glucocorticoid resistance.
  • These genetic alterations could affect messenger RNA (mRNA) stability.
  • The mutations might influence interactions with other regulatory factors, impacting gene expression.

Related Concept Videos